340B HEALTH for 340B HEALTH
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2023 | $203,296 | Replaced |
| 4th Quarter - Report | Jan 20, 2023 | $203,296 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
The 340B Drug Pricing Program; H.R. 5376 - The Inflation Reduction Act; H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; S.4659 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Fiscal Year 2023 Omnibus Appropriations Bill, H.R. 4390, The Protect 340B Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG DOGGETT | — |
| THOMAS ALFRED O'DONNELL | — |
| AMANDA SELLERS SMITH | — |
| MAUREEN TESTONI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.